流感疫苗接种后高分辨率抗体动态揭示2014-2022年季节中以弱应答为主及不常见但持久的免疫
该研究开展了两项新的疫苗研究并分析了12项既往疫苗研究,以高分辨率绘制接种日至接种后1年针对H3N2和H1N1流感疫苗的抗体应答。抗体动力学分为弱应答、短暂应答和持久应答三种表型,在几乎所有季节、年龄组、性别、接种前滴度和疫苗剂量中,≥50%的受种者表现为弱应答。接种后1个月的峰值倍数变化与长期应答强相关,且应答早期单个时间点可预测接种后1年的应答。
要点
- ≥50%的受种者在几乎所有季节、年龄组、性别、接种前滴度和疫苗剂量中表现为弱应答。
- 短暂应答者峰值倍数变化常为4倍后回落至基线,持久应答者达≥16倍并维持至1年。
- 应答早期单个时间点(第7-8天或第21天)可预测个体接种后1年的应答。
核心结论
- 流感疫苗在部分受种者中几乎无应答,而在另一些受种者中诱导强烈且持久的抗体免疫,各流感季节均可见显著异质性。
研究设计与样本
- 开展了两项新的疫苗研究,并分析了12项既往疫苗研究,高分辨率追踪接种日至接种后1年针对H3N2和H1N1流感的抗体应答。
主要发现
- 抗体动力学对应三种主要表型:弱应答(1个月和1年时倍数变化<4倍)、短暂应答(1个月时≥4倍,1年时<4倍)、持久应答(1个月和1年时均≥4倍)。
- 在几乎所有季节、年龄组、性别、接种前滴度和高剂量或标准剂量疫苗中,≥50%的受种者为弱应答。
- 接种后1个月峰值倍数变化与长期应答强相关,短暂应答者峰值倍数变化常为4倍后衰减回基线,持久应答者达≥16倍并维持至1年。
- 利用弱、短暂和持久轨迹,应答早期单个时间点(第7-8天或第21天)可预测个体接种后1年的应答。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Most influenza vaccine studies evaluate acute antibody responses 1 month post-vaccination, yet the finer details of immune kinetics remain poorly understood. Here, we conducted two new vaccine studies and analyzed 12 prior vaccine studies to map antibody responses against H3N2 and H1N1 influenza in high resolution from the day of vaccine administration out to 1 year post-vaccination. Antibody kinetics corresponded to three major phenotypes, namely, weak (<4x fold-change at 1 month and 1 year), transient (≥4x at 1 month, <4x at 1 year), or durable (≥4x at 1 month and 1 year). Surprisingly, ≥50 % of vaccine recipients were weak across nearly all seasons, age groups, sexes, pre-vaccination titers, and high or standard vaccine doses examined. Peak fold-change at 1 month post-vaccination was strongly associated with the long-term response, with transient responders often achieving a peak fold-change of 4x and then decaying back to baseline, while durable responders reached ≥16x fold-change and maintained comparable titers out to 1 year. Using the weak, transient, and durable trajectories, a single time point early in the response (days 7-8 or 21) predicted an individual's response out to 1 year post-vaccination. These results highlight the stark heterogeneity that is consistently seen across influenza seasons, where the vaccine elicits little-to-no response in some but strong and long-lasting antibody immunity in others.
引用
- Lane A, Quach HQ, Ovsyannikova IG, et al. High-resolution antibody dynamics following influenza vaccination reveal predominantly weak responses as well as infrequent but durable immunity across the 2014-2022 seasons. Vaccine. 2025. PMID: 40946064. doi:10.1016/j.vaccine.2025.127677
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。